Retrospective research (2007-2012) was conducted on 500 patients with drug-resistant primary tuberculosis treated by DOTS-plus PS SLE Azerbaijan. The aim of the study was to establish a new strategy of identifying TB within the penitentiary system, aimed at early determination of the disease and soonest commencement of treatment of the patients with second generation medications. Results of the study as well as the analysis of multivariable indicators have confirmed that passive identification (ORa=1.13) of the patients and delayed commencement of the treatment by more than 3 months from determination (ORa=1.01), are the main prognosis factors of amplified drug resistance.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!